{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:57:40Z","timestamp":1789581460621,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"7th Framework Programme of DG Research and Innovation of the European Commission","doi-asserted-by":"publisher","award":["603019"],"award-info":[{"award-number":["603019"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cmi.2019.09.006","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:22:53Z","timestamp":1568719373000},"page":"579-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":279,"title":["Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans"],"prefix":"10.1016","volume":"26","author":[{"given":"P.J.","family":"Maver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Poljak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.09.006_bib1","series-title":"Cervical cancer: an NCD we can overcome","year":"2018"},{"key":"10.1016\/j.cmi.2019.09.006_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1470-2045(18)30836-2","article-title":"Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020\u201399: a modelling study","volume":"20","author":"Simms","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cmi.2019.09.006_bib3","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.cmi.2015.05.041","article-title":"Towards cervical cancer eradication: joint force of HPV vaccination and HPV-based cervical cancer screening","volume":"21","author":"Poljak","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.09.006_bib4","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cmi.2019.09.006_bib5","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 5","key":"10.1016\/j.cmi.2019.09.006_bib6","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2019.09.006_bib7","doi-asserted-by":"crossref","first-page":"dju153","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cmi.2019.09.006_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.09.006_bib9","series-title":"European guidelines for quality assurance in cervical cancer screening","article-title":"Screening for cervical cancer with primary testing for human papillomavirus, S1","author":"Ronco","year":"2015"},{"key":"10.1016\/j.cmi.2019.09.006_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pvr.2015.06.006","article-title":"European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination","volume":"1","author":"von Karsa","year":"2015","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.cmi.2019.09.006_bib11","doi-asserted-by":"crossref","first-page":"i4924","DOI":"10.1136\/bmj.i4924","article-title":"Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands","volume":"355","author":"Dijkstra","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2019.09.006_bib12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2019.09.006_bib13","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S1470-2045(18)30536-9","article-title":"Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study","volume":"19","author":"Malag\u00f3n","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cmi.2019.09.006_bib14","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1016\/j.cmi.2019.09.006_bib15","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcv.2015.10.023","article-title":"Commercially available molecular tests for human papillomaviruses (HPV): 2015 update","volume":"76","author":"Poljak","year":"2016","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2019.09.006_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.cmi.2019.09.006_bib17","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcv.2015.09.014","article-title":"VALGENT: a protocol for clinical validation of human papillomavirus assays","volume":"76","author":"Arbyn","year":"2016","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2019.09.006_bib18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.09.006_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ypmed.2018.12.021","article-title":"HPV-based cervical screening: rationale, expectations and future perspectives of the new Dutch screening programme","volume":"119","author":"Polman","year":"2019","journal-title":"Prev Med"},{"key":"10.1016\/j.cmi.2019.09.006_bib21","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/ijc.31212","article-title":"Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women","volume":"142","author":"Gultekin","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cmi.2019.09.006_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pvr.2019.03.002","article-title":"Mega HPV laboratories for cervical cancer control: challenges and recommendations from a case study of Turkey","volume":"7","author":"Gultekin","year":"2019","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.cmi.2019.09.006_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejca.2016.09.008","article-title":"Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms","volume":"68","author":"Ronco","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cmi.2019.09.006_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/cyt.12652","article-title":"Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience","volume":"30","author":"Veijalainen","year":"2019","journal-title":"Cytopathology"},{"issue":"Suppl 1","key":"10.1016\/j.cmi.2019.09.006_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-5013(14)73068-7","article-title":"[Gu\u00eda de cribado del cancer de cuello de \u00fatero en Espa\u0144a, 2014]","volume":"57","author":"Torn\u00e9 Blad\u00e9","year":"2014","journal-title":"Prog Obstet Ginecol"},{"issue":"Suppl 1","key":"10.1016\/j.cmi.2019.09.006_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0212-6567(18)30362-7","article-title":"[Recomendaciones de prevenci\u00f3n del c\u00e1ncer. Actualizaci\u00f3n PAPPS 2018]","volume":"50","author":"Marzo-Castillejo","year":"2018","journal-title":"Aten Primaria"},{"key":"10.1016\/j.cmi.2019.09.006_bib29","article-title":"Safe implementation of HPV testing in the Norwegian cervical cancer screening programme","volume":"137","author":"Trop\u00e9","year":"2017","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.cmi.2019.09.006_bib31","doi-asserted-by":"crossref","first-page":"l240","DOI":"10.1136\/bmj.l240","article-title":"Primary cervical screening with high risk human papillomavirus testing: observational study","volume":"364","author":"Rebolj","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2019.09.006_bib34","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cmi.2019.09.006_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ijc.31043","article-title":"Status of implementation and organization of cancer screening in the European Union member states\u2014summary results from the second European screening report","volume":"142","author":"Basu","year":"2018","journal-title":"Int J Cancer"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19304914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19304914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:25:39Z","timestamp":1761117939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19304914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1198743X19304914"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.09.006","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}